Consider the following facts: In breast cancer alone, there has been over 2000 inhibitors developed in research labs, though only one or two are effective in clinics.
Thus , undoubtedly, there is an yawning gap between research in labs and clinics.
We need to reduce this gap.
We need to stratify patients better or target drugs better to patients Who will benefit from the different inhibitors.
We at Dr Jeyapaul Cancer Foundation Trust are committed to raise funds for design of treatment targeted to be effective in the clinics.
So we are a charitable, non profit organisation dedicated to translational research work (60%of funds) and for treatment of young patients not able to afford it ( 40% of funds)